Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarction

Nature Clinical Practice. Cardiovascular Medicine
Jozef BartunekMarc Vanderheyden

Abstract

It is still unclear whether the timing of intracoronary stem cell therapy affects the therapeutic response in patients with reperfused myocardial infarction. The natural course of healing the infarction and the presence of putative homing signals within the damaged myocardium appear to favor cell engraftment during the transendothelial passage in the early days after reperfusion. However, the adverse inflammatory environment, with its high oxidative stress, might be deleterious if cells are administered too early after reperfusion. In addition, current studies use mostly unfractionated cells and it remains to be addressed whether specific cell types, and their enrichment, would be better suited to augmenting the recovery at later time points. Here we highlight several aspects of the timing of intracoronary stem cell therapy and focus on time-related questions that are relevant to the design of future experimental and basic studies.

References

Dec 18, 2001·Cardiovascular Research·Nikolaos G FrangogiannisMark L Entman
Feb 14, 2003·The New England Journal of Medicine·Jonathan M HillToren Finkel
Jun 26, 2004·Circulation Research·Min NianPeter Liu
Sep 11, 2004·Circulation Research·Francisco Fernández-AvilésAna Sánchez
Jan 5, 2005·Basic Research in Cardiology·Vincent F M SegersGilles W De Keulenaer
Oct 26, 2005·Circulation·Kuniharu MatsunoChihiro Yabe-Nishimura
Dec 7, 2005·Circulation·John Alfred CarrRoberto M Lang

❮ Previous
Next ❯

Citations

Jun 2, 2009·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·S A J ChamuleauR Bolli
Dec 25, 2010·Journal of Cardiovascular Translational Research·Nabil DibAnn Campbell
Nov 19, 2009·Circulation. Cardiovascular Imaging·Rutger-Jan SwijnenburgJoseph C Wu
Feb 24, 2009·Canadian Journal of Physiology and Pharmacology·Zeynep Tokcaer-KeskinKamil C Akcali
Oct 1, 2012·Drug Delivery and Translational Research·Byeong Hee HwangSamir Mitragotri
Jan 1, 2014·Translational Research : the Journal of Laboratory and Clinical Medicine·Otmar PfisterGabriela M Kuster
Aug 31, 2010·Translational Research : the Journal of Laboratory and Clinical Medicine·Mohamad Amer AlaitiMarco A Costa
Aug 21, 2009·The Journal of Thoracic and Cardiovascular Surgery·Vien Khach LaiManuel Galiñanes
Apr 9, 2008·Journal of Molecular and Cellular Cardiology·Victoria L T Ballard, Jay M Edelberg
Mar 25, 2008·Experimental Hematology·Silvia CharwatDietmar Glogar
Feb 27, 2009·Journal of Cellular and Molecular Medicine·Shuning ZhangJunbo Ge
Apr 19, 2012·Basic & Clinical Pharmacology & Toxicology·Jeppe Grøndahl Rasmussen, Ulf Simonsen
Dec 20, 2013·European Journal of Clinical Investigation·Montserrat RigolMagda Heras
Apr 22, 2014·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Liudmila ZakharovaMohamed A Gaballa
Apr 24, 2013·International Journal of Cardiology·Zekeriya ArslanMurat Tavlaşoğlu
Mar 20, 2010·JACC. Cardiovascular Interventions·Nabil DibUNKNOWN International Society for Cardiovascular Translational Research
Feb 13, 2009·Clinical Pharmacology and Therapeutics·J BartunekA Terzic
Feb 28, 2006·Nature Clinical Practice. Cardiovascular Medicine·Warren ShermanTomasz Siminiak
Dec 5, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Sheik WiselPeriannan Kuppusamy
Jan 6, 2009·Internal Medicine Journal·C M ZubrinichM F Sutherland
Jan 11, 2020·BMJ Case Reports·Jack CallumPatrick Carroll
Apr 21, 2011·Cardiovascular Research·S MaggioliniF Achilli
Aug 26, 2020·Pharmaceutical Research·Reyaj MikraniXiaohui Zhou
Mar 25, 2017·Acta Biochimica Et Biophysica Sinica·Xiaoyan LiuXiaoqiang Ding
Mar 7, 2020·European Journal of Pharmacology·Ziwei LiuXiaohui Zhou
Jun 30, 2019·ACS Nano·Kabir S DhadaLaura J Suggs

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.